Use of antipolymer antibody assay in recipients of silicone breast implants

Lancet

Volumn 349, Issue 9050, 1997, Pages 449-454

  Tenenbaum, Scott A ^a   Rice, Janet C ^c   Espinoza, Luis R ^d   Cuéllar, Marta L ^d   Plymale, Douglas R ^b   Sander, David M ^b   Williamson, Linda L ^a   Haislip, Allyson M ^a   Gluck, Oscar S ^e   Tesser, John R P ^e   Nogy, Leigh ^f   Stribrny, Kathleen M ^e   Bevan, Julie A ^e   Garry, Robert F ^a,b  

^a Dept of Microbiology and Immunology ^*  (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^e Arizona Rheumatology Center   (United States)

^f Affinitech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; SILICONE;

ARTICLE; AUTOIMMUNITY; BREAST ENDOPROSTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYMPTOM;

EID: 0031046131     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07131-0     Document Type: Article

References (29)

1. Silverman BG, Brown SL, Bright RA, Kaczmarek RG, Arrowsmith-Lowe JB, Kessler DA. Reported complications of silicone gel breast implants: an epidemiological review. Ann Intern Med 1996; 124: 744-56.
2. Bridges AJ, Vasey FB. Silicone breast implants: history, safety, and potential complications. Arch Intern Med 1993; 153: 2638-44.
3. Cook RR, Harrison MC, LeVier RR. The breast implant controversy. Arthritis Rheum 1994; 37: 153-57.
4. Kessler DA, Merkatz RB, Schapiro R. A call for higher standards for breast implants. JAMA 1993; 270: 2607-08.
5. Angell M. Evaluating the health risks of breast implants: the interplay of medical science, the law and public opinion. N Engl J Med 1996; 334: 1512-18.
6. Bridges AJ. Silicone implant controversy continues. Lancet 1994; 344: 1451-52.
7. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 1993; 118: 929-36.
8. Teuber SS, Gershwin ME. Autoantibodies and clinical rheumatic complaints in two children of women with silicone gel breast implants. Int Arch Allergy Immunol 1994; 103: 105-08.
9. Levine MD. Scleroderma-like esophageal disease in children of mothers with silicone breast implants. JAMA 1994; 272: 769.
10. Guillaume JC, Roujeau JC. Touraine R. Systemic lupus after breast prosthesis. Ann Dermatol Venereol 1984; 111: 703-04.
11. Brozena SJ, Fenske NA, Cruse CW, et al. Human adjuvant disease following augmentation mammoplasty. Arch Dermatol 1988; 124: 1383-86.
12. Spiera H. Scleroderma after silicone augmentation mammoplasty. JAMA 1988; 260: 236-38.
13. Germain BF. Silicone breast implants and rheumatic disease. Bull Rheum Dis 1991; 41: 1-5.
14. Angell M. Do breast implants cause systemic disease? Science in the courtroom. N Engl J Med 1994; 330: 1748-49.
15. Cook RR. Scleroderma-like esophageal disease in children of mothers with silicone breast implants. JAMA 1994; 272: 767-68.
16. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995; 332: 1666-70.
17. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LR. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994; 330: 1697-702.
18. Hennekens CH, Lee I-M, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professions: a retrospective cohort study. JAMA 1996; 275: 616-21.
19. Brautbar N. The silicone breast implant controversy: silicone toxicity and autoimmunity. Natl Med Leg J 1995; 6: 1, 4-7.
20. Sergott TJ, Limoli JP, Baldwin CM Jr, Laub DR. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 1986; 78: 104-14.
21. Cuéllar ML, Scopelitis E, Tenenbaum SA, et al. Serum antinuclear antibodies in women with silicone breast implants. J Rheumatol 1995; 22: 236-40.
22. Press RI, Peebles CL, Kumagai Y, Ochs RL, Tan EM. Antinuclear autoantibodies in women with silicone breast implants. Lancet 1992; 340: 1304-07.
23. Claman HN, Robertson AD. Antinuclear antibodies and breast implants. West J Med 1994; 160: 225-28.
24. Bridges AJ. Autoantibodies in patients with silicone implants. Semin Arthritis Rheum 1994; 24 (suppl 1): 54-60.
25. Tenenbaum SA, Silveira LH, Martínez-Osuna P, Cuéllar ML, Garry RF, Espinoza LR. Identification of a novel autoantigen recognized in silicone associated connective tissue disease. Arthritis Rheum 1992; 73 (suppl): 25 abstr.
26. Tenenbaum SA, Cuéllar ML, Garry RF, Espinoza LR. Production of antibodies to partially cross-linked polymers in silicone breast implant recipients. Arthritis Rheum 1993; S118: A123 (abstr).
27. Fox RI, Robinson C, Curd J, Michelson P, Bone R, Howell FV. First international symposium on Sjogren's syndrome: suggested criteria for classification. Scand J Rheumatol 1986; 61: 28-30.
28. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
29. Zambinski M, Messner R, Mandel J. AntiDNA antibodies in technicians handling lupus blood. Proceedings of the 53rd General Meeting of the American College of Rheumatology 1989: s25 (abstr).